More stories

  • in

    US supreme court blocks ruling limiting access to abortion pill

    The supreme court decided on Friday to temporarily block a lower court ruling that had placed significant restrictions on the abortion drug mifepristone.The justices granted emergency requests by the justice department and the pill’s manufacturer, Danco Laboratories, to halt a preliminary injunction issued by a federal judge in Texas. The judge’s order would significantly limit the availability of the medication as litigation proceeds in a challenge by anti-abortion groups.The decision offered a victory to the Biden administration as it defends access to the drug in the latest fierce legal battle over reproductive rights in the US. The president praised the decision and said he continues to stand by the FDA’s approval of the pill.“As a result of the supreme court’s stay, mifepristone remains available and approved for safe and effective use while we continue this fight in the courts,” Biden said in a statement. “The stakes could not be higher for women across America. I will continue to fight politically driven attacks on women’s health.”The court’s ruling means that access to mifepristone will remain unchanged at least into next year as appeals play out and patients can still get medication abortions with the drug in states where it was previously available.Reproductive rights groups celebrated the ruling, while cautioning it does not necessarily herald the final outcome of the case. “This is very welcome news, but it’s frightening to think that Americans came within hours of losing access to a medication that is used in most abortions in this country and has been used for decades by millions of people to safely end a pregnancy or treat a miscarriage,” said Jennifer Dalven, director of the Reproductive Freedom Project at the American Civil Liberties Union. “Make no mistake, we aren’t out of the woods by any means. This case, which should have been laughed out of court from the very start, will continue on.”The decision came in the most pivotal abortion rights case to make its way through the courts since Roe v Wade was overturned last year. More than half of abortions in the US are completed using pills.The case was brought by a conservative Christian legal group arguing the Food and Drug Administration improperly approved mifepristone more than 23 years ago.The Biden administration vigorously defended the FDA against the charge, emphasizing its rigorous safety reviews of the drug and the potential for regulatory chaos if plaintiffs and judges not versed in scientific and medical arguments begin to undermine the agency’s decision-making.Conservative justices Clarence Thomas and Samuel Alito dissented, with Alito writing that the Biden administration and Danco “are not entitled to a stay because they have not shown that they are likely to suffer irreparable harm in the interim”.The order granting the stay was unsigned, so it is not known how each of the other seven justices voted.The case has moved quickly through the courts in recent weeks, as contradicting rulings have thrown the future of the drug into question.In early April, a federal judge in Texas, Matthew Kacsmaryk, first ruled in the lawsuit brought by a coalition of anti-abortion groups to suspend the FDA’s 23-year-old authorization of mifepristone entirely, writing that the agency wrongly approved the drug. After a challenge by the Biden administration in the fifth circuit court of appeals, a divided three-judge panel said the drug’s approval could stand, but imposed restrictions on it, limiting its use to seven weeks of pregnancy instead of the current 10-week limit, and banning delivery of the pill by mail.The Biden administration then asked the supreme court to intervene before the restrictions went into effect. Alito twice stayed the lower court ruling, keeping access to mifepristone unaltered while the court deliberated.Complicating matters, another federal judge issued a ruling directly contradicting Kacsmaryk’s, ordering the FDA to refrain from making any changes to the availability of mifepristone in 18 jurisdictions.That judge – Judge Thomas O Rice, in Washington – reaffirmed that order after the fifth circuit’s ruling.Both the Biden administration and pharmaceutical companies have warned of regulatory chaos around drug approvals, should the supreme court allow the restrictions on mifepristone to go into effect.“If this ruling were to stand, then there will be virtually no prescription, approved by the FDA, that would be safe from these kinds of political, ideological attacks,” president Biden said in a written statement after the Kacsmaryk’s decision in early April.The US vice-president, Kamala Harris, echoed the point in a statement responding to the appellate decision: “If this decision stands, no medication – from chemotherapy drugs, to asthma medicine, to blood pressure pills, to insulin – would be safe from attacks.” More

  • in

    Feinstein absence blocks push for supreme court chief Thomas testimony

    Asked if he would subpoena the chief justice of the US supreme court for testimony over corruption allegations against the conservative justice Clarence Thomas, the chair of the Senate judiciary committee made clear his frustration with a continued absence from the panel that has left Democrats unable to make such a move.“It takes a majority,” Dick Durbin of Illinois said on Thursday. “I don’t have a majority.”Democrats do not have a committee majority because of the absence of Dianne Feinstein, the 89-year-old California senator who has been hospitalised with shingles.Some Democrats have called for Feinstein to resign, while others have labelled such calls as sexist. Feinstein has said she hopes to return.But Republicans blocked a move for a temporary committee replacement and the situation has slowed Democrats’ pace in confirming federal judges, a priority after four years in which Donald Trump sent conservatives to courts around the US.Thomas is the senior conservative on a supreme court tilted 6-3 to the right after three confirmations under Trump. This month, he has been the subject of bombshell reporting from ProPublica, about his long relationship with and acceptance of gifts from Harlan Crow, a rightwing megadonor and collector of Hitler memorabilia.Crow’s links to Thomas’s wife, the rightwing activist Ginni Thomas, have also come under the spotlight.Thomas and Crow deny wrongdoing, the justice saying he was advised he did not have to declare gifts, the donor saying he and Thomas did not discuss politics or business before the court.On Thursday, the Guardian detailed business a conservative group affiliated with Crow has had before the court in the period of his friendship with Thomas.Observers have said Thomas broke the law. But though supreme court justices are subject to federal ethics rules, they essentially govern themselves.On Thursday, Durbin said he had invited the chief justice to testify about the Thomas allegations on 2 May. The senator also said Roberts could send another justice in his place, pointing to testimony by justices Antonin Scalia and Stephen Breyer in 2011.Speaking to reporters, Durbin said: “There’s been no discussion of subpoenas for anyone at this point.”skip past newsletter promotionafter newsletter promotionRepublicans opposed the request.John Cornyn of Texas said: “I would not recommend that the chief accept his invitation because it would be a circus.”Josh Hawley of Missouri said Durbin was trying to “turn the screws” on Roberts and claimed the situation was “inching toward” a constitutional crisis.But there is pressure on Democrats to act over what Chris Van Hollen of Maryland has called the “unacceptable” way in which “the supreme court has exempted itself from the accountability that applies to all other members of our federal courts”.Writing to Roberts, Durbin described “a steady stream of revelation regarding justices falling short of the ethical standards expected of other federal judges and, indeed, of public servants generally”.Earlier this week, Richard Blumenthal of Connecticut suggested Thomas and Crow should be the ones to receive subpoenas. More

  • in

    US supreme court to decide on abortion pill access after extending deadline

    The supreme court is poised to decide whether to preserve access to a widely used abortion medication, after extending its deadline to act until at least Friday.Less than a year after the court’s conservative majority overturned Roe v Wade and eliminated a constitutional right to an abortion, the justices are now weighing new legal questions in an escalating case in Texas with potentially sweeping implications for women’s reproductive health and the federal drug approval process.For now, the court is not weighing the merits of a legal challenge brought by abortion opponents seeking to suspend the Food and Drug Administration’s 23-year-old approval of mifepristone. At issue before the court is whether to allow restrictions on the drug imposed by a lower court that would sharply limit access to the drug, including in states where abortion remains legal.The justices had initially set a deadline of 11.59pm on Wednesday, but that afternoon, Justice Samuel Alito issued a brief order extending the court’s deadline by 48 hours. The one-sentence order provided no explanation for the delay but indicated the court expects to act before midnight on Friday.The legal clash began in Texas, with US district judge Matthew Kacsmaryk’s ruling to revoke the FDA’s approval of mifepristone, a drug first approved more than two decades ago and used by more than 5 million women to end their pregnancies.The Biden administration immediately appealed the decision, which it assailed as an unprecedented attack on the the FDA’s decision-making. The US court of appeals for the 5th circuit then temporarily blocked the Texas decision, preserving access to mifepristone while the legal case plays out, but reversed regulatory actions taken by the FDA since 2016 that expanded access to the pill. Those changes include allowing patients to receive the drug by mail, and extending its use from seven to 10 weeks of pregnancy.The Biden administration and drugmakers next asked the supreme court to pause the lower court’s ruling, arguing that reimposing the barriers would create chaos in the marketplace and cause confusion for providers and patients.Alliance Defending Freedom, a coalition of anti-abortion doctors and organizations, has argued that the FDA failed to follow proper protocols when it approved mifepristone and has since ignored safety risks of the medication. Medical experts have said the claims are dubious and not based on scientific evidence.Complicating the legal landscape around this case, a federal judge in Washington state, Thomas Rice, issued a contradictory ruling in a separate lawsuit brought by Democratic attorneys general in 17 states and the District of Columbia. The order, which Rice reaffirmed after the appeals ruling in the Texas case, blocked the FDA from limiting the availability of mifepristone in those states.Since the fall of Roe, more than a dozen US states have banned or severely restricted abortion. But many other states have moved in the opposite direction, approving legislation and ballot measures that protect abortion rights. Amid the patchwork legal landscape, attention has turned to medication abortion, which can be obtained by mail and administered at home.Mifepristone is the first pill in a two-drug regimen that is the most common method of ending a pregnancy, accounting for more than half of all abortions in the US. Decades of research and data from hundreds of medical studies have shown that it is both a safe and effective way to end a pregnancy.The drug first won FDA approval in 2000, and over the years the agency has loosened restrictions on its use. Those changes include allowing the drug’s use from seven to 10 weeks of pregnancy, lowering the dosage of mifepristone needed to safely end a pregnancy, allowing the pills to be delivered by mail, eliminating the in-person doctors visit requirement and approving a generic version.Depending on how the justices rule, those changes could be reversed, at least while the case proceeds through the courts. On Wednesday, GenBioPro, the manufacturer of the generic form of mifepristone, sued the FDA to keep the drug on the market, setting up a new front in the legal battle over access to abortion medication. More

  • in

    Judicial record undermines Clarence Thomas defence in luxury gifts scandal

    Earlier this month, the supreme court justice Clarence Thomas put out a statement in which he addressed the storm of criticism that has engulfed him following the blockbuster ProPublica report that revealed his failure to disclose lavish gifts of luxury vacations and private-jet travel from a Texan real estate magnate.Thomas confirmed that the Dallas billionaire and Republican mega-donor Harlan Crow and his wife Kathy were “among our dearest friends”. Thomas admitted, too, that he and his wife Ginni had “joined them on a number of family trips during the more-than-a-quarter-century we have known them”.The justice, who is the longest-serving member of the nation’s highest court and arguably its most staunch conservative, insisted he had taken advice that “this sort of personal hospitality from close personal friends” did not have to be reported under federal ethics laws. He emphasized that the friend in question “did not have business before the court”.But a close look at Thomas’s judicial activities from the time he became friends with Crow, in the mid-1990s, suggests that the statement might fall short of the full picture. It reveals that a conservative organization affiliated with Crow did have business before the supreme court while Thomas was on the bench.In addition, Crow has been connected to several groups that over the years have lobbied the supreme court through so-called “amicus briefs” that provide legal arguments supporting a plaintiff or defendant.In 2003, the anti-tax group the Club for Growth joined other rightwing individuals and organisations, including the Republican senator Mitch McConnell and the National Rifle Association (NRA), in attempting to push back campaign finance restrictions on election spending.At the time of the legal challenge, from at least 2001 to 2004, Crow was a member of the Club for Growth’s prestigious “founders committee”. Though little is known about the role of the committee, it clearly commanded some influence over the group’s policymaking.During the course of a 2005 investigation into likely campaign finance violations by the Club for Growth, the Federal Election Commission (FEC) noted that rank-and-file club members could “vote on an annual policy question selected by the founders committee”.Crow has also been a major donor to the club, contributing $275,000 to its coffers in 2004 and a further $150,000 two years later.The 2003 legal challenge championed by the Club for Growth targeted the McCain-Feingold Act, which had been passed with cross-aisle backing the previous year. The legislation placed new controls on the amount of “soft money” political party committees and corporations could spend on elections.On appeal, a consolidated version of the lawsuit, Mitch McConnell v FEC, was taken up by the supreme court. In a majority ruling, the court allowed the most important elements of the McCain-Feingold Act to stand (though they were later nullified by the supreme court’s contentious 2010 Citizens United ruling).Thomas was livid. He issued a 25-page dissenting opinion that sided heavily with the anti-regulation stance taken by the Club for Growth and its rightwing allies. Thomas began his opinion by breathlessly accusing his fellow justices of upholding “what can only be described as the most significant abridgment of the freedoms of speech and association since the civil war”.By the time Thomas issued his opinion in December 2003 he had already forged his deep relationship with Crow. According to the billionaire, they first met at a conference in Dallas in 1994 – by which time Thomas had already been nominated by George HW Bush to the most powerful court in the land.The businessman had already showered Thomas with several lavish gifts before the McCain-Feingold challenge reached his court. Thomas disclosed for instance a 1997 flight from Washington to northern California on Crow’s private jet to attend an all-male retreat at Bohemian Grove at which the justice went on to become a regular guest.There was also a Bible once owned by Frederick Douglass, then valued at $19,000. In 2001 Crow made a $150,000 donation to create a Clarence Thomas wing within the Savannah, Georgia, library the justice frequented as a child.The federal law 28 US Code section 455 requires any federal judge – including the nine supreme court justices – to recuse themselves from any proceeding “in which his impartiality might reasonably be questioned”.ProPublica’s explosive investigation earlier this month exposed undeclared gifts and travel that have continued to be bestowed by the billionaire on Thomas to this day. They included a nine-day vacation with Ginni in Indonesia in the summer of 2019 the cost of which probably exceeded $500,000.In a later report, ProPublica revealed that in 2014 Thomas sold his mother’s home in Savannah to Crow. That transaction was also left undisclosed.The ProPublica disclosures have prompted a debate about the need for greater scrutiny of the conduct of supreme court justices. Top Democrats have called for an official inquiry into Thomas’s behavior and for all the justices to be subject to a strict ethics code.The progressive Democratic congresswoman Alexandria Ocasio-Cortez, speaking on CNN, decried Crow’s largesse as “very serious corruption” and called for Thomas to be impeached.Gabe Roth, executive director of Fix the Court, a non-partisan group which advocates supreme court reform, said that a crisis of trust in Thomas’s ethical judgments had been bubbling below the surface for some time. “The reason that it is so salient now is that the supreme court has grown exponentially in power since Justice Thomas took that first private plane ride in 1997 – when the court becomes the most powerful government body, then ethics issues become all the more critical.”The Guardian contacted Thomas at the supreme court but did not receive a response.This week, the normally media-shy Crow, who has assets valued at $30bn and who has donated at least $13m to Republicans, gave an in-depth interview to the Dallas Morning News. He claimed the furore around his relations with Thomas was a “political hit-job” by the liberal media.He insisted he and Thomas were just friends who spent their time talking about their kids and animals. “We talk about dogs a lot,” he said.Asked whether he ever considered their friendship as a ticket to quid pro quo, he replied: “Every single relationship – a baby’s relationship to his mom – has some kind of reciprocity.”Crow’s office, in a statement to the Guardian, disputed any relevance of Crow’s links with the Club for Growth, his friendship with Thomas, and the justice’s opinion in the McConnell v FEC case. “Harlan Crow was not a party to the litigation, was only a financial supporter of Club for Growth, and had no role whatsoever in any Club for Growth litigation decisions.”The statement continued: “Any insinuation that Justice Thomas wrote his opinion in this case because Harlan Crow was a supporter is ridiculous as Justice Thomas had already expressed these same views in a previous case, Nixon v Shrink MO PAC.”The billionaire’s office insisted that Thomas’s skepticism of the constitutionality of campaign finance regulation “was established before he had even met Harlan Crow”.Crow has never personally come before the supreme court, and denies ever trying to influence Thomas on any legal or political issue. But he has served on the boards of at least three conservative groups that have lobbied the supreme court through amicus briefs. Early in his friendship with Thomas, Crow sat on the national board of the now defunct Center for the Community Interest, which filed at least eight amicus briefs in supreme court cases backing rightwing causes such as sweeping crime off the streets and countering pornography.He has also been a trustee for more than 25 years of the American Enterprise Institute, a thinktank advancing free enterprise ideas that has filed several supporting briefs to the court. In 2001 AEI gave Thomas a bust of Abraham Lincoln then valued at $15,000.Crow is an overseer of the Hoover Institution, a conservative thinktank based at Stanford University. In February, Hoover senior fellows led an amicus brief filed to Thomas and his fellow justices challenging the $400bn student loan debt-relief program introduced by Joe Biden.The supreme court is likely to rule on whether the scheme can go ahead this summer. In oral arguments in February, Thomas was among the rightwing justices who hold the supermajority who indicated they were skeptical of the program, raising the possibility that the court will scupper the hopes of more than 40 million Americans eligible for the debt relief. More

  • in

    Democratic senators condemn federal judge’s ruling to block abortion drug

    Top Democratic senators across the US are pushing back after a federal judge in Texas decided to block the FDA-approved abortion drug mifepristone.On Sunday, the New York senator Kirsten Gillibrand criticized as an “outrage” Judge Matthew Kacsmaryk’s decision, which is currently halted until at least Wednesday 19 April by the supreme court.Speaking to CNN, Gillibrand said: “To take away the right to have medicine is an extension of taking away this right to privacy, to say we can’t have medicine sent by doctors by mail to people across the country is further invading into this right to privacy, where the court and government has a right to what’s in your mail, and who you’re talking to and what communications you’re having. It’s an outrage.”She went on to condemn the supreme court, which in June 2022 decided to overturn Roe v Wade, a ruling that declared the constitutional right to an abortion for nearly half a century.Gillibrand said the supreme court’s decision was an “all-out assault on women’s reproductive freedom,” adding: “What we are seeing in these Republican legislatures as well as these very conservative courts is a continuation of that assault.”Similarly, the Minnesota senator Amy Klobuchar called Kacsmaryk’s decision “unbelievable”.“What is going to be next? Is that judge going to not like birth control pills? Are we going to have a judge that doesn’t like [cholesterol medication] Lipitor? There’s a reason that Congress gave the FDA the power to make these decisions about safety,” Klobuchar told ABC.“I can tell you who is harmed by this. It’s women that are going to have to take a bus across the country from Texas to Minnesota or to Illinois. That’s the problem right now,” she added, pledging to “aggressively litigate” the ruling if the supreme court decides to uphold it.The Wisconsin senator Tammy Baldwin, meanwhile, said that Kacsmaryk “is not guided by science”.“What we have in Texas is a judge who is not guided by science, but is part of an extreme Republican concerted effort to ban abortion nationwide,” Baldwin told NBC.“We do not need judges, politicians or government telling women about what sort of healthcare they can have. It is an issue that is not only playing out in the court in Texas, but in the state of Florida, with the governor signing a near six-week ban, Idaho forbidding travel out of state for minors, Wisconsin where we’ve gone back to literally 1849. That is the date our criminal abortion ban was passed and that’s 174 years ago,” Baldwin said.Last month, Baldwin and the Connecticut senator Richard Blumenthal, a Democrat, led the introduction of the Women’s Health Protection Act of 2023, which would safeguard abortion rights nationwide and “restore the right to comprehensive reproductive healthcare for millions of Americans”.skip past newsletter promotionafter newsletter promotionFollowing Kacsmaryk’s ruling, the justice department and the drug’s manufacturer, Danco Laboratories, asked the supreme court to intervene in an attempt to halt the restrictions, which would have limited mifepristone’s use after seven weeks of pregnancy as well as ban mail delivery of the drug. Mifepristone is currently approved until 10 weeks.On Friday, the conservative supreme court justice Samuel Alito temporarily blocked the Texas lower court ruling and instead imposed on to it a five-day stay, allowing the justices more time to decide on their next steps.Alito’s move allows for the country’s most common method of pregnancy termination to remain unchanged until at least the end of Wednesday.Despite nationwide outrage from progressive lawmakers and reproductive rights activists, conservative lawmakers have defended the growing wave of various abortion bans.In an interview on Sunday with NBC, the Republican senator Bill Cassidy of Louisiana said reactions to the Texas ruling are “totally alarmist”.“It’s totally alarmist. And by the way, when did the FDA think they could go above the law?” Cassidy said, adding: “Dobbs, I think, was the correct decision,” in reference to the supreme court’s overturning of federal abortion rights last year.Cassidy’s comments come two days after Florida’s Republican governor, Ron DeSantis, signed into law a six-week abortion ban across the state, which currently has a 15-week ban. More

  • in

    ‘They created this’: are Republicans willing to lose elections to retain their abortion stance?

    Democrats have taken multiple actions in response to what they say is a “draconian” and “dangerous” decision by a federal judge in Texas threatening access to the most commonly used method of abortion in the US.Several Democratic governors have begun to stockpile doses of the drugs used in medication abortions. Nearly every Democrat in Congress signed onto an amicus brief urging an appeals court to stay the decision, while some called on the Biden administration to simply “ignore” the ruling, should it be allowed to stand. A group of House Democrats introduced a bill that would give the Food and Drug Administration (FDA) final approval over drugs used in medication abortion.Their fury over the ruling has been met with relative silence from Republicans.Only a handful of congressional Republicans offered immediate comment on judge Matthew Kacsmaryk’s decision last week to revoke the FDA’s 23-year-old approval of the abortion pill mifepristone. Just a fraction of Republicans on Capitol Hill signed onto an amicus brief urging an appeals court to uphold the ruling. And among the party’s national field of Republican presidential nominees, just one – the former vice president, Mike Pence – unabashedly praised the decision.The starkly different reactions underscores just how dramatically the politics of abortion have shifted since last June, when conservatives achieved their once-unimaginable goal of overturning Roe v Wade.For decades, Republicans relied on abortion to rally their conservative base, calling for the reversal of Roe v Wade and vowing to outlaw the procedure if given the chance. But since the supreme court’s ruling in Dobbs v Jackson Women’s Health, abortion has emerged as a potent issue for Democrats, galvanizing voters furious over the thicket of state bans and restrictions ushered in by the decision.Republicans have struggled to respond, lacking a unified policy on abortion in the nearly 10 months since the landmark decision.“Dobbs really did get Republicans, especially elected Republicans, running scared,” said Jon Schweppe, policy director at the conservative American Principles Project.Polling has consistently found a clear majority of Americans believe abortion should remain legal in all or most cases, though partisan divisions have deepened over the years. A new survey released by the Pew Research Center this week showed that by a margin of more than 2 to 1, Americans believe medication abortion, which is at the center of the current legal battle, should be legal in their state.‘Let the states work this out’A post-Dobbs backlash fueled a string of victories for abortions rights, including in more conservative states, and powered Democratic victories in last year’s November midterm elections. And this month, just days before the Texas ruling on mifepristone, abortion rights were a dominant force in a liberal judge’s landslide victory in a key race for a Wisconsin supreme court seat.“It’s no surprise that GOP candidates are scared to tie themselves to a decision that is wildly out of step with what voters want,” Mini Timmaraju, the president of Naral Pro-Choice American told reporters this week. “They can’t be eager to repeat last week’s double-digit walloping of extremist judicial candidate, Dan Kelly, in Wisconsin.”In that race, Kelly’s opponent, judge Janet Protasiewicz, had effectively promised voters that if she won, flipping the ideological balance of the court from conservative to liberal, the new majority would overturn Wisconsin’s 1849 abortion ban.“People understood the stakes and they were ready to vote for Judge Protasiewicz,” said Timmaraju, whose group was active in the contest.Now, with the 2024 presidential election looming, an increasingly vocal group of Republicans are urging moderation on abortion, warning that the uncompromising positions of their party’s culturally conservative base risk alienating crucial swing voters.“This is an issue that Republicans have been largely on the wrong side of,” congresswoman Nancy Mace, a Republican from South Carolina, said in a recent appearance on CNN.Mace, who considers herself “pro-life”, said her party had “not shown compassion towards women” since the fall of Roe. She has urged flexibility, pushing Republicans to expand access to contraception and include exceptions for abortions in cases of rape, incest or when the life of the mother is at risk or the fetus is no longer viable.Since June, Republican-led legislatures have charged ahead with new restrictions. More than a dozen states ban abortion, with several other Republican-led state legislatures considering new restrictions this session.On Thursday, the Florida legislature voted to prohibit abortions after six weeks – before many women realize they are pregnant – delivering a major policy victory for the state’s Republican governor, Ron DeSantis. Hours later, DeSantis, who is widely expected to run for president in 2024, quietly signed the ban into law with little fanfare, underscoring just how complicated the issue has become for Republicans.In Nebraska, the state legislature is in the process of debating a six-week ban. But even in the reliably conservative state, some Republican lawmakers are floating an alternative that would expand the window to 12 weeks, a sign that a ban any earlier in pregnancy could stoke public outcry.One option floated as a politically palatable “compromise” is a proposal by South Carolina senator Lindsey Graham that would implement a federal ban on abortions after 15 weeks of pregnancy.But the legislation divided Republicans and ultimately only attracted a handful of co-sponsors when he introduced it last year ahead of the midterms. Several Republicans, including the Senate minority leader, Mitch McConnell, argued that limits on abortion should be set by the states.Asked whether he supported Graham’s proposal, Senator Tim Scott, a Republican from South Carolina who this week formed an exploratory committee for a 2024 presidential run, said was “100% pro-life” but declined to answer the question directly. He clarified later that he would back a federal ban at 20 weeks of pregnancy.Nikki Haley, Donald Trump’s former UN ambassador who is running for the nomination, urged Republicans to seek consensus on the issue, asserting that she was “pro-life” but did not “judge anyone who is pro-choice”.“Let’s let the states work this out,” Haley said, according to the Des Moines Register. “If Congress decides to do it – but don’t get in that game of them saying ‘how many weeks, how many’ – no. Let’s first figure out what we agree on.”DeSantis has sought to position himself as a reliable ally of the anti-abortion movement, hoping his support of a six-week ban will appeal to social conservatives searching for an alternative to Trump in the early-voting states Iowa and South Carolina.Earlier this year, Trump, whose conservative supreme court appointees enabled Roe to be struck down, angered abortion opponents when he warned that abortion is a political liability for Republicans and blamed extremism on the issue for their lackluster performance in the 2022 midterms.‘Ostrich strategy’In the escalating legal battle over access to medication abortion, supreme court justice Samuel Alito on Friday temporarily halted a federal appeals court ruling that would have reimposed restrictions on mifepristone. The stay will expire on Wednesday while the court deliberate next steps.Reproductive rights advocates say the ongoing threat to medication abortion nationwide makes clear that Republicans never actually believed abortion was an issue best handled by the states, as Alito wrote in his 2022 decision overturning the federal right to abortion.“They are seeking a nationwide ban – but they are not going to stop there,” Jennifer Dalven, director of the ACLU Reproductive Freedom Project, told reporters this week. “We are already seeing attacks on birth control.”As a starting point, Schweppe believes social conservatives must be willing to compromise on a federal ban, possibly accepting legislation that falls well short of their long-held goal to end all abortions. He urged Republicans to adopt positions that are broadly popular with wide swaths of voters, including allowances for pregnancies that result from rape or incest, or when the health or life of the mother is at risk.“We have to be honest about where the fault lines lie,” he said. “Exceptions are what drives voter sentiment. That’s what Democrats are attacking us on.”Many leading abortion opponents blame recent losses on Republicans’ embrace of a so-called “ostrich strategy” – avoiding the topic or trying to change the subject – not their opposition to abortion.“Republicans have cowered in fear as the consultants and campaign advisors tell them not to talk about abortion,” Penny Young Nance, the chief executive and president of evangelical Christian group, Concerned Women for America. In the Wisconsin supreme court race, she said the conservative’s defeat was an example of what happens when Republicans are badly outspent and fail to “boldly” defend their position on an issue that has been a defining policy of American conservatism.“The winning strategy is to tell the truth about the left’s extremist position on the issue that is out of [sync] with the views of the American people,” Nance said in an email.As Republicans search for a path forward, Democrats, confident public opinion is on their side, are already preparing to make abortion a central theme of the coming election cycles.“Even though some in the GOP are trying to stay quiet about the Texas ruling, back home they’re still passing and signing abortion bans,” Timmaraju said.“They created this reality,” she added. “They cannot run away from it.” More

  • in

    Fate of US abortion drug hangs in balance ahead of Friday deadline

    FDA authorization for a key abortion drug could be nullified after Friday, unless an appeals court acts on a Biden administration request to block last week’s ruling suspending approval of the drug.The drug, mifepristone, is used in more than half of all the abortions in the US. The ruling, issued by a federal judge in Texas, applies across the country.Writing that the ruling would “inflict grave harm on women, the medical system, and the public” if it went into effect, the Department of Justice on Monday requested the fifth US circuit court of appeals temporarily block Judge Matthew Kacsmaryk’s ruling while the appeals process plays out.The issue may ultimately fall into the hands of the US supreme court and its conservative supermajority, which eradicated abortion rights last year by overturning Roe v Wade.Kacsmaryk stayed his decision for seven days to allow the Biden administration time to appeal. Shortly after the ruling from Texas, Obama-appointed Washington district judge Thomas Rice issued a contradictory ruling that directs the FDA to keep the drug available in 17 states.The dueling opinions set the stage for the supreme court to possibly intervene.“On one hand, you have a ruling that says to defer to the expertise of the FDA and keep the status quo while another says to second-guess the FDA with junk science,” says David S Cohen, law professor at Drexel University, who focuses on reproductive rights.“When you have different rulings from different federal courts it is more likely for the US supreme court to get involved.”The New Orleans-based appellate court is one of the most conservative in the US. Republican appointees comprise three-quarters of its bench, with six judges nominated by former President Donald Trump. The court has routinely ruled against the Biden administration and on behalf of Texas’s abortion laws.If the appeals court declines to put a hold on Kacsmaryk’s ruling, then the Biden administration would likely appeal to the high court.“It’s possible that the mifepristone issue makes its way to the [Supreme] Court this week, either because the Fifth Circuit refuses to even temporarily pause Kacsmaryk’s ruling, or because it takes too long to do anything,” writes Steve Vladeck, a constitutional law professor at The University of Texas.In his ruling, Kacsmaryk echoed the arguments of the anti-abortion groups that brought the case, writing that the FDA disregarded science that the drug causes harm, despite repeated studies finding it extremely safe. Legal experts say that the decision – the first time the judiciary has intervened to overturn FDA approval of a drug – could create a precedent that throws the entire drug approvals system into disarray.More than 250 pharmaceutical and biomedical companies who strongly denounced Kacsmaryk’s ruling in an open letter and warned that it could upend the FDA approval process as well as the entire US healthcare system.“Judicial activism will not stop here,” they cautioned. “If courts can overturn drug approvals without regard for science and evidence, or for the complexity required to fully vet the safety and efficacy of new drugs, any medicine is at risk for the same outcome as mifepristone.”Mifepristone is used for abortion, miscarriage management and other medical care. If access to the drug is upended, abortion providers have said they will continue to prescribe the second of the two-drug protocol for abortions. However, that drug, misoprostol, has been found to be somewhat less effective and associated with more painful side effects than the combination of pills.With the mifepristone in doubt, the Biden administration asked Rice, the district judge in Washington, for clarification on how to proceed if the Texas ruling goes into effect, given that his decision orders the government to take no action that would hinder its availability.Legal experts have argued that the FDA does not need to enforce Kacsmaryk’s ruling, even if it goes into effect.The ruling does not formally compel the FDA to seize the pills and take them off the market, Cohen says, and leaves the door open for the Biden administration to apply what’s called “enforcement discretion”, which would entail issuing guidance protecting the distribution of mifepristone. In the past, the FDA has granted drug manufacturers this type of safe harbor even in the absence of agency authorization, including for infant formula.“The ruling does not force the FDA to do anything,” says Cohen. “It’s up to the FDA to determine what to do next. They can use enforcement discretion to protect access to mifepristone. We shouldn’t read into Kacsmaryk’s ruling as having more power than it does – it is limited – and there’s a huge amount of authority the FDA can retain.” More